Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk

Angela Hsu, Andrea Card, Susan Xiaoqin Lin, Sean Mota, Olveen Carrasquillo, Andrew Moran

Research output: Contribution to journalArticle

5 Scopus citations


After randomized trials failed to support the use ofhormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausalwomen declined. Our analysis of 1999-2000 and 2003-2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19% (from 27.6 to 8.4%; P < .001) among women with CVD versus 3% (from 19.8 to 16.8%; P = .68) among low-risk women, suggestingthatmost of the drop in HRT use may be among women prescribed HRT as an unproven treatment to prevent CVD.

Original languageEnglish (US)
Pages (from-to)2184-2187
Number of pages4
JournalAmerican journal of public health
Issue number12
StatePublished - Dec 1 2009
Externally publishedYes


ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this